Jakarta - Delayed Quote IDR
PT Sarana Meditama Metropolitan Tbk (SAME.JK)
278.00
-2.00
(-0.71%)
At close: May 23 at 4:11:36 PM GMT+7
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,714,087,407.37
1,706,381,445.19
1,531,660,499.52
1,393,542,157.50
1,271,584,061.68
Cost of Revenue
1,209,071,628.50
1,192,181,857.20
1,072,346,094.13
916,611,668.05
729,018,194.35
Gross Profit
505,015,778.87
514,199,587.98
459,314,405.39
476,930,489.45
542,565,867.33
Operating Expense
408,233,840.25
421,015,859.50
427,720,201.78
448,437,716.34
338,008,838.24
Operating Income
96,781,938.62
93,183,728.49
31,594,203.61
28,492,773.12
204,557,029.09
Net Non Operating Interest Income Expense
-79,906,702.69
-81,751,909.42
-69,959,041.94
-39,416,384.33
-28,374,730.94
Pretax Income
44,244,848.34
38,169,052.53
13,007,302.14
17,224,606.91
155,750,863.67
Tax Provision
17,017,251.48
17,563,607.61
-4,734,976.11
7,641,911.88
1,520,281.65
Net Income Common Stockholders
19,951,244.53
11,848,736.15
12,252,193.95
4,347,230.84
144,169,265.52
Diluted NI Available to Com Stockholders
19,951,244.53
11,848,736.15
12,252,193.95
4,347,230.84
144,169,265.52
Basic EPS
1.17
0.69
0.71
0.25
10.64
Diluted EPS
1.17
0.69
0.71
0.25
10.64
Basic Average Shares
17,149,351.50
17,147,164
17,136,918.65
17,130,326.18
13,543,872.62
Diluted Average Shares
17,149,351.50
17,147,164
17,136,918.65
17,130,326.18
13,543,872.62
Total Operating Income as Reported
106,585,754.34
102,429,025.24
47,326,837.16
34,284,784.51
184,125,594.61
Total Expenses
1,617,305,468.75
1,613,197,716.70
1,500,066,295.90
1,365,049,384.38
1,067,027,032.59
Net Income from Continuing & Discontinued Operation
19,951,244.53
11,848,736.15
12,252,193.95
4,347,230.84
144,169,265.52
Normalized Income
19,970,738.99
12,205,884.47
8,133,003.63
3,402,524.23
164,401,269.10
Interest Income
3,527,818.16
4,138,212.14
6,025,836.08
6,797,282.14
12,719,471.38
Interest Expense
76,542,496.34
79,160,492.51
69,777,962.33
40,387,510.72
41,094,202.32
Net Interest Income
-79,906,702.69
-81,751,909.42
-69,959,041.94
-39,416,384.33
-28,374,730.94
EBIT
120,787,344.67
117,329,545.04
82,785,264.47
57,612,117.63
196,845,065.99
EBITDA
186,032,814.97
191,097,894.17
170,961,063.81
155,792,512.01
266,621,203.68
Reconciled Cost of Revenue
1,209,071,628.50
1,192,181,857.20
1,072,346,094.13
916,611,668.05
729,018,194.35
Reconciled Depreciation
65,245,470.30
73,768,349.13
88,175,799.34
98,180,394.38
69,776,137.69
Net Income from Continuing Operation Net Minority Interest
19,951,244.53
11,848,736.15
12,252,193.95
4,347,230.84
144,169,265.52
Total Unusual Items Excluding Goodwill
-31,678.50
-457,882.47
5,281,013.23
1,211,162.32
-20,431,434.48
Total Unusual Items
-31,678.50
-457,882.47
5,281,013.23
1,211,162.32
-20,431,434.48
Normalized EBITDA
186,064,493.47
191,555,776.64
165,680,050.59
154,581,349.70
287,052,638.16
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-12,184.04
-100,734.14
1,161,822.91
266,455.71
-199,430.90
12/31/2021 - 1/25/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade